Patent · US Active

Combination therapies and methods of use thereof

US11946094B2 · kind B2 · utility

0Cited by

8References

6Claims

0Family size

Assignee

Augusta University Research Institute, Inc. · US

Inventors

Jin She · Chapel Hill, US
Robert Schleifer · Sugar Hill, US
Shuchun Li · Chongqing, CN

Key dates

Filing date	Dec 10, 2018
Grant date	Apr 2, 2024
Priority date	—
Expiry date	Jan 5, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for identifying drug resistant genes and compositions containing agents that downregulate these genes in combination with a cancer therapeutic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.